Literature DB >> 34371184

METTL1/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression.

Jieyi Ma1, Hui Han2, Ying Huang3, Chunlong Yang2, Siyi Zheng2, Tiancai Cai4, Jiong Bi5, Xiaohui Huang5, Ruiming Liu5, Libin Huang3, Yifeng Luo6, Wen Li7, Shuibin Lin8.   

Abstract

Mis-regulated epigenetic modifications in RNAs are associated with human cancers. The transfer RNAs (tRNAs) are the most heavily modified RNA species in cells; however, little is known about the functions of tRNA modifications in cancers. In this study, we uncovered that the expression levels of tRNA N7-methylguanosine (m7G) methyltransferase complex components methyltransferase-like 1 (METTL1) and WD repeat domain 4 (WDR4) are significantly elevated in human lung cancer samples and negatively associated with patient prognosis. Impaired m7G tRNA modification upon METTL1/WDR4 depletion resulted in decreased cell proliferation, colony formation, cell invasion, and impaired tumorigenic capacities of lung cancer cells in vitro and in vivo. Moreover, gain-of-function and mutagenesis experiments revealed that METTL1 promoted lung cancer growth and invasion through regulation of m7G tRNA modifications. Profiling of tRNA methylation and mRNA translation revealed that highly translated mRNAs have higher frequencies of m7G tRNA-decoded codons, and knockdown of METTL1 resulted in decreased translation of mRNAs with higher frequencies of m7G tRNA codons, suggesting that tRNA modifications and codon usage play an essential function in mRNA translation regulation. Our data uncovered novel insights on mRNA translation regulation through tRNA modifications and the corresponding mRNA codon compositions in lung cancer, providing a new molecular basis underlying lung cancer progression.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  METTL1; N(7)-methylguanosine; WDR4; lung cancer; m(7)G; tRNA modification; translation

Mesh:

Substances:

Year:  2021        PMID: 34371184      PMCID: PMC8636169          DOI: 10.1016/j.ymthe.2021.08.005

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  33 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Distribution and frequencies of post-transcriptional modifications in tRNAs.

Authors:  Magdalena A Machnicka; Anna Olchowik; Henri Grosjean; Janusz M Bujnicki
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 3.  tRNA modification and cancer: potential for therapeutic prevention and intervention.

Authors:  Lauren Endres; Michael Fasullo; Rebecca Rose
Journal:  Future Med Chem       Date:  2019-02-12       Impact factor: 3.808

4.  Further delineation of the phenotype caused by biallelic variants in the WDR4 gene.

Authors:  A Trimouille; E Lasseaux; P Barat; C Deiller; S Drunat; C Rooryck; B Arveiler; D Lacombe
Journal:  Clin Genet       Date:  2017-09-29       Impact factor: 4.438

Review 5.  Biosynthesis and function of posttranscriptional modifications of transfer RNAs.

Authors:  Basma El Yacoubi; Marc Bailly; Valérie de Crécy-Lagard
Journal:  Annu Rev Genet       Date:  2012-08-16       Impact factor: 16.830

6.  ALKBH1-Mediated tRNA Demethylation Regulates Translation.

Authors:  Fange Liu; Wesley Clark; Guanzheng Luo; Xiaoyun Wang; Ye Fu; Jiangbo Wei; Xiao Wang; Ziyang Hao; Qing Dai; Guanqun Zheng; Honghui Ma; Dali Han; Molly Evans; Arne Klungland; Tao Pan; Chuan He
Journal:  Cell       Date:  2016-10-13       Impact factor: 41.582

7.  Speech and language delay in a patient with WDR4 mutations.

Authors:  Xiang Chen; Yanyan Gao; Lin Yang; Bingbing Wu; Xinran Dong; Bo Liu; Yulan Lu; Wenhao Zhou; Huijun Wang
Journal:  Eur J Med Genet       Date:  2018-03-26       Impact factor: 2.708

8.  tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cells.

Authors:  Mayumi Okamoto; Mamoru Fujiwara; Masato Hori; Kaoru Okada; Futoshi Yazama; Hiroaki Konishi; Yegui Xiao; Guangying Qi; Fumio Shimamoto; Takahide Ota; Achim Temme; Masaaki Tatsuka
Journal:  PLoS Genet       Date:  2014-09-18       Impact factor: 5.917

9.  Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific.

Authors:  Tong Wang; Yizhi Cui; Jingjie Jin; Jiahui Guo; Guibin Wang; Xingfeng Yin; Qing-Yu He; Gong Zhang
Journal:  Nucleic Acids Res       Date:  2013-03-21       Impact factor: 16.971

10.  Methyltransferase-like 1 regulates lung adenocarcinoma A549 cell proliferation and autophagy via the AKT/mTORC1 signaling pathway.

Authors:  Chen Wang; Wei Wang; Xiaodan Han; Longxia Du; Aili Li; Guojin Huang
Journal:  Oncol Lett       Date:  2021-02-25       Impact factor: 2.967

View more
  34 in total

1.  N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma.

Authors:  Binbin Chen; Wei Jiang; Ying Huang; Jian Zhang; Peng Yu; Lirong Wu; Hao Peng
Journal:  Oncogene       Date:  2022-02-26       Impact factor: 9.867

2.  Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.

Authors:  Chuanhao Zhang; Dong Zhou; Zhe Wang; Zaishuang Ju; Jiabei He; Genghao Zhao; Ruoyu Wang
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

3.  Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.

Authors:  Fei Lu; Jingyan Gao; Yu Hou; Ke Cao; Yaoxiong Xia; Zhengting Chen; Hui Yu; Li Chang; Wenhui Li
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

Review 4.  Novel roles of METTL1/WDR4 in tumor via m7G methylation.

Authors:  Wenli Cheng; Aili Gao; Hui Lin; Wenjuan Zhang
Journal:  Mol Ther Oncolytics       Date:  2022-06-07       Impact factor: 6.311

5.  N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma.

Authors:  Parbatraj Regmi; Zhi-Qiang He; Thongher Lia; Aliza Paudyal; Fu-Yu Li
Journal:  Front Genet       Date:  2022-06-06       Impact factor: 4.772

Review 6.  The potential role of N7-methylguanosine (m7G) in cancer.

Authors:  Yuejun Luo; Yuxin Yao; Peng Wu; Xiaohui Zi; Nan Sun; Jie He
Journal:  J Hematol Oncol       Date:  2022-05-19       Impact factor: 23.168

7.  METTL1 promotes hepatocarcinogenesis via m7 G tRNA modification-dependent translation control.

Authors:  Zhihang Chen; Wanjie Zhu; Shenghua Zhu; Kaiyu Sun; Junbin Liao; Haining Liu; Zihao Dai; Hui Han; Xuxin Ren; Qingxia Yang; Siyi Zheng; Baogang Peng; Sui Peng; Ming Kuang; Shuibin Lin
Journal:  Clin Transl Med       Date:  2021-12

8.  N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis.

Authors:  Hui Han; Chunlong Yang; Jieyi Ma; Shuishen Zhang; Siyi Zheng; Rongsong Ling; Kaiyu Sun; Siyao Guo; Boxuan Huang; Yu Liang; Lu Wang; Shuang Chen; Zhaoyu Wang; Wei Wei; Ying Huang; Hao Peng; Yi-Zhou Jiang; Junho Choe; Shuibin Lin
Journal:  Nat Commun       Date:  2022-03-18       Impact factor: 14.919

9.  METTL1-m7 G-EGFR/EFEMP1 axis promotes the bladder cancer development.

Authors:  Xiaoling Ying; Bixia Liu; Zusen Yuan; Yapeng Huang; Cong Chen; Xu Jiang; Haiqing Zhang; Defeng Qi; Shulan Yang; Shuibin Lin; Junhang Luo; Weidong Ji
Journal:  Clin Transl Med       Date:  2021-12

10.  Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.

Authors:  Jie Chen; Kang Li; Jianwen Chen; Xiaochen Wang; Rongsong Ling; Maosheng Cheng; Zhi Chen; Fangfang Chen; Qianting He; Shuai Li; Caihua Zhang; Yizhou Jiang; Qianming Chen; Anxun Wang; Demeng Chen
Journal:  Cancer Commun (Lond)       Date:  2022-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.